Related Experiment Video
Updated: Feb 5, 2026

Evaluation of Microbial Safety of Dairies using Bacterial Proteomic Profiling via MALDI Approach
Published on: October 7, 2025
Safety profile after prolonged C3 inhibition
Edimara S Reis1, Nadja Berger1, Xin Wang1
1Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Systemic inhibition of complement component 3 (C3) using compstatin in adult non-human primates did not impair immune function or increase infection susceptibility. This suggests C3 inhibition is safe for therapeutic use in adults.
Area of Science:
- Immunology
- Biochemistry
- Pharmacology
Background:
- Complement component 3 (C3) is crucial for immune responses, including phagocytosis and microbial clearance.
- C3 deficiency in humans is linked to bacterial infections, particularly in early life.
- Therapeutic C3 inhibition is approached cautiously due to its central role in immunity.
Purpose of the Study:
- To investigate the safety and immunological effects of prolonged systemic C3 inhibition.
- To assess the impact of the C3 inhibitor compstatin (Cp40) on healthy adult non-human primates.
- To evaluate potential risks of infection or immune compromise associated with C3 inhibition.
Main Methods:
- Cynomolgus monkeys received subcutaneous Cp40 for varying durations (1 week to 3 months).
- Plasma C3 and Cp40 levels were monitored to confirm C3 inhibition.
- Hematological, biochemical, immunological parameters, and wound healing were assessed.
- A biodistribution study was conducted in rhesus monkeys.
Main Results:
- Complete systemic C3 inhibition was achieved and maintained.
- No significant differences were observed in hematological, biochemical, or immunological parameters between Cp40-treated and control groups.
- Cp40 treatment did not lead to infection in skin wounds and showed a trend toward accelerated healing.
- Cp40 distribution correlated with C3 presence in blood-rich organs.
Conclusions:
- Systemic C3 inhibition with Cp40 is well-tolerated in adult non-human primates.
- Prolonged C3 inhibition does not appear to compromise the immune system or increase infection risk in healthy adults.
- These findings support the potential therapeutic use of C3 inhibitors in adult populations.
Related Concept Videos
Feedback Inhibition
Survey Safety
Household Wiring And Electrical Safety
Enzyme Inhibition
Inhibition of Cdk Activity
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...

